Patent · US Active

Proteolysis-resistant capsid of chimeric hepatitis E virus as an oral delivery vector

US8906863B2 · kind B2 · utility

3Cited by
0References
18Claims
0Family size

Assignee

Inventors

Key dates

Filing dateSep 1, 2011
Grant dateDec 9, 2014
Priority date—
Expiry dateSep 1, 2031

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2770/28142
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

This invention provides a peptide/nucleic acid composition for oral/mucosal, dual-modal activation of immune protection systems.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.